[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611940":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":46,"locations":52,"responsibleParty":318,"collaborators":30,"id":320,"slug":321,"hasResults":322,"nctId":323,"briefTitle":324,"officialTitle":325,"acronym":30,"eligibilityCriteria":326,"healthyVolunteers":322,"sex":327,"minAge":328,"maxAge":30,"enrollmentInfo":329,"targetDuration":30,"studyType":332,"phases":333,"briefSummary":335,"conditions":336,"keywords":30,"overallStatus":55,"whyStopped":30,"lastUpdateSubmitDate":338,"lastUpdatePostDateStruct":339,"startDateStruct":342,"completionDateStruct":344,"leadSponsor":346,"locationsCount":347},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"MK-4716 Dose Escalation","EXPERIMENTAL","Participants receive MK-4716 at varying dose levels and schedules.",[13],"Drug: MK-4716",{"label":15,"type":10,"description":16,"interventionNames":17},"MK-4716 + Pembrolizumab","Participants will receive MK-4716 + Pembrolizumab",[13,18],"Biological: Pembrolizumab",{"label":20,"type":10,"description":21,"interventionNames":22},"MK-4716 + Cetuximab","Participants will receive MK-4716 + Cetuximab",[13,23],"Biological: Cetuximab",[25,31,39],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","MK-4716","Oral administration",[20,15,9],null,{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"BIOLOGICAL","Pembrolizumab","Intravenous administration",[15],[37,38],"Keytruda","MK-3475",{"type":32,"name":40,"description":34,"armGroupLabels":41,"otherNames":30},"Cetuximab",[20],[43],{"name":44,"affiliation":5,"role":45},"Medical Director","STUDY_DIRECTOR",[47],{"name":48,"role":49,"phone":50,"phoneExt":30,"email":51},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[53,71,84,97,112,125,137,150,165,178,190,205,214,223,237,249,261,274,283,297,306],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Rutgers Cancer Institute of New Jersey ( Site 0052)","RECRUITING","New Brunswick","New Jersey","08903","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-74.45182,40.48622,{"lat":65,"lon":64},[68],{"name":69,"role":49,"phone":70,"phoneExt":30,"email":30},"Study Coordinator","732-253-3939",{"facility":72,"status":55,"city":73,"state":74,"zip":75,"country":59,"countryCode":60,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"NEXT Oncology ( Site 0051)","Irving","Texas","75039",{"type":62,"coordinates":77},[78,79],-96.94889,32.81402,{"lat":79,"lon":78},[82],{"name":69,"role":49,"phone":83,"phoneExt":30,"email":30},"972-893-8800",{"facility":85,"status":55,"city":86,"state":87,"zip":88,"country":59,"countryCode":60,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"NEXT Virginia ( Site 0054)","Fairfax","Virginia","22031",{"type":62,"coordinates":90},[91,92],-77.30637,38.84622,{"lat":92,"lon":91},[95],{"name":69,"role":49,"phone":96,"phoneExt":30,"email":30},"703-783-4510",{"facility":98,"status":55,"city":99,"state":100,"zip":101,"country":102,"countryCode":103,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Blacktown Hospital ( Site 0455)","Sydney","New South Wales","2148","Australia","AU",{"type":62,"coordinates":105},[106,107],151.20732,-33.86785,{"lat":107,"lon":106},[110],{"name":69,"role":49,"phone":111,"phoneExt":30,"email":30},"98818000",{"facility":113,"status":55,"city":114,"state":115,"zip":116,"country":102,"countryCode":103,"cosmosGeoPoint":117,"geoPoint":121,"contacts":122},"Monash Health ( Site 0452)","Clayton","Victoria","3168",{"type":62,"coordinates":118},[119,120],145.11667,-37.91667,{"lat":120,"lon":119},[123],{"name":69,"role":49,"phone":124,"phoneExt":30,"email":30},"+61474769510",{"facility":126,"status":55,"city":127,"state":115,"zip":128,"country":102,"countryCode":103,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"The Alfred Hospital ( Site 0453)","Melbourne","3004",{"type":62,"coordinates":130},[131,132],144.96332,-37.814,{"lat":132,"lon":131},[135],{"name":69,"role":49,"phone":136,"phoneExt":30,"email":30},"+61 3 9076 3129",{"facility":138,"status":55,"city":139,"state":140,"zip":141,"country":102,"countryCode":103,"cosmosGeoPoint":142,"geoPoint":146,"contacts":147},"One Clinical Research ( Site 0454)","Nedlands","Western Australia","6009",{"type":62,"coordinates":143},[144,145],115.8073,-31.98184,{"lat":145,"lon":144},[148],{"name":69,"role":49,"phone":149,"phoneExt":30,"email":30},"+61862799466",{"facility":151,"status":55,"city":152,"state":153,"zip":154,"country":155,"countryCode":156,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Princess Margaret Cancer Centre ( Site 0001)","Toronto","Ontario","M5G 2M9","Canada","CA",{"type":62,"coordinates":158},[159,160],-79.39864,43.70643,{"lat":160,"lon":159},[163],{"name":69,"role":49,"phone":164,"phoneExt":30,"email":30},"4165865371",{"facility":166,"status":55,"city":167,"state":168,"zip":169,"country":155,"countryCode":156,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"Centre Hospitalier de l'Université de Montréal ( Site 0003)","Montreal","Quebec","H2X 0A9",{"type":62,"coordinates":171},[172,173],-73.58781,45.50884,{"lat":173,"lon":172},[176],{"name":69,"role":49,"phone":177,"phoneExt":30,"email":30},"5148908000",{"facility":179,"status":55,"city":180,"state":168,"zip":181,"country":155,"countryCode":156,"cosmosGeoPoint":182,"geoPoint":186,"contacts":187},"Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0002)","Québec","G1J 1Z4",{"type":62,"coordinates":183},[184,185],-71.21454,46.81228,{"lat":185,"lon":184},[188],{"name":69,"role":49,"phone":189,"phoneExt":30,"email":30},"418-525-4444",{"facility":191,"status":55,"city":192,"state":193,"zip":194,"country":195,"countryCode":196,"cosmosGeoPoint":197,"geoPoint":201,"contacts":202},"FALP-UIDO ( Site 0101)","Santiago","Region M. de Santiago","7500921","Chile","CL",{"type":62,"coordinates":198},[199,200],-70.64827,-33.45694,{"lat":200,"lon":199},[203],{"name":69,"role":49,"phone":204,"phoneExt":30,"email":30},"+56962290773",{"facility":206,"status":55,"city":192,"state":193,"zip":207,"country":195,"countryCode":196,"cosmosGeoPoint":208,"geoPoint":210,"contacts":211},"Pontificia Universidad Catolica de Chile-CICUC ( Site 0103)","8330073",{"type":62,"coordinates":209},[199,200],{"lat":200,"lon":199},[212],{"name":69,"role":49,"phone":213,"phoneExt":30,"email":30},"+56934331806",{"facility":215,"status":55,"city":192,"state":193,"zip":216,"country":195,"countryCode":196,"cosmosGeoPoint":217,"geoPoint":219,"contacts":220},"Bradfordhill ( Site 0102)","8420383",{"type":62,"coordinates":218},[199,200],{"lat":200,"lon":199},[221],{"name":69,"role":49,"phone":222,"phoneExt":30,"email":30},"+56229490970",{"facility":224,"status":55,"city":225,"state":30,"zip":226,"country":227,"countryCode":228,"cosmosGeoPoint":229,"geoPoint":233,"contacts":234},"Rambam Health Care Campus ( Site 0252)","Haifa","3109601","Israel","IL",{"type":62,"coordinates":230},[231,232],34.99928,32.81303,{"lat":232,"lon":231},[235],{"name":69,"role":49,"phone":236,"phoneExt":30,"email":30},"+97247772688",{"facility":238,"status":55,"city":239,"state":30,"zip":240,"country":227,"countryCode":228,"cosmosGeoPoint":241,"geoPoint":245,"contacts":246},"Rabin Medical Center ( Site 0253)","Petah Tikva","4941492",{"type":62,"coordinates":242},[243,244],34.88747,32.08707,{"lat":244,"lon":243},[247],{"name":69,"role":49,"phone":248,"phoneExt":30,"email":30},"+97239377377",{"facility":250,"status":55,"city":251,"state":30,"zip":252,"country":227,"countryCode":228,"cosmosGeoPoint":253,"geoPoint":257,"contacts":258},"Sheba Medical Center ( Site 0251)","Ramat Gan","5265601",{"type":62,"coordinates":254},[255,256],34.81065,32.08227,{"lat":256,"lon":255},[259],{"name":69,"role":49,"phone":260,"phoneExt":30,"email":30},"+97235303030",{"facility":262,"status":55,"city":263,"state":30,"zip":264,"country":265,"countryCode":30,"cosmosGeoPoint":266,"geoPoint":270,"contacts":271},"Seoul National University Hospital ( Site 0501)","Seoul","03080","South Korea",{"type":62,"coordinates":267},[268,269],126.9784,37.566,{"lat":269,"lon":268},[272],{"name":69,"role":49,"phone":273,"phoneExt":30,"email":30},"82-2-2072-0242",{"facility":275,"status":55,"city":263,"state":30,"zip":276,"country":265,"countryCode":30,"cosmosGeoPoint":277,"geoPoint":279,"contacts":280},"Asan Medical Center ( Site 0502)","05505",{"type":62,"coordinates":278},[268,269],{"lat":269,"lon":268},[281],{"name":69,"role":49,"phone":282,"phoneExt":30,"email":30},"82-2-3010-1727",{"facility":284,"status":55,"city":285,"state":30,"zip":286,"country":287,"countryCode":288,"cosmosGeoPoint":289,"geoPoint":293,"contacts":294},"Hospital General Universitari Vall d Hebron ( Site 0360)","Barcelona","08035","Spain","ES",{"type":62,"coordinates":290},[291,292],2.15899,41.38879,{"lat":292,"lon":291},[295],{"name":69,"role":49,"phone":296,"phoneExt":30,"email":30},"+34932746000",{"facility":298,"status":55,"city":285,"state":30,"zip":299,"country":287,"countryCode":288,"cosmosGeoPoint":300,"geoPoint":302,"contacts":303},"Hospital Clinic de Barcelona ( Site 0362)","08036",{"type":62,"coordinates":301},[291,292],{"lat":292,"lon":291},[304],{"name":69,"role":49,"phone":305,"phoneExt":30,"email":30},"+34932274208",{"facility":307,"status":55,"city":308,"state":30,"zip":309,"country":287,"countryCode":288,"cosmosGeoPoint":310,"geoPoint":314,"contacts":315},"Hospital Universitario Fundacion Jimenez Diaz ( Site 0361)","Madrid","28040",{"type":62,"coordinates":311},[312,313],-3.70256,40.4165,{"lat":313,"lon":312},[316],{"name":69,"role":49,"phone":317,"phoneExt":30,"email":30},"+34915504800x2805",{"type":319,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100611940","a-clinical-study-of-mk-4716-in-people-with-certain-solid-tumors-mk-4716-001-100611940",false,"NCT07247110","A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)","A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of MK-4716 as Monotherapy and as Part of Combination Therapy in Participants With KRAS-Altered Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Has a confirmed diagnosis of locally advanced unresectable or metastatic solid tumor\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Must demonstrate presence of Kirsten rat sarcoma viral oncogene homolog (KRAS) alteration\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Has received at least 1 prior line of systemic therapy for locally advanced unresectable or metastatic disease\n* Arm MK-4716 + Pembrolizumab: Has a confirmed diagnosis of metastatic non-small cell lung cancer\n* Arm MK-4716 + Pembrolizumab: Must demonstrate presence of KRAS alteration\n* Arm MK-4716 + Pembrolizumab: Must be untreated\n* Has measurable disease\n* Has the ability to swallow and retain oral medication\n\nExclusion Criteria:\n\n* Arm MK-4716 + Pembrolizumab: Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of study intervention\n* Arm MK-4716 + Pembrolizumab: Has received any prior immunotherapy and was discontinued from that treatment\n* Arm MK-4716 + Pembrolizumab: Has active autoimmune disease that has required systemic treatment in the past 2 years. Hormonal supplementation (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed\n* History of human immunodeficiency virus infection\n* Has a known additional malignancy that is progressing or has required active treatment within the past 2 years\n* Has a known active central nervous system metastases and\u002For carcinomatous meningitis\n* History of (noninfectious) pneumonitis\u002Finterstitial lung disease that required steroids or has current pneumonitis\u002Finterstitial lung disease\n* Has active infection requiring systemic therapy\n* Has Hepatitis B or Hepatitis C virus infection\n* History of stem cell\u002Fsolid organ transplant\n* Has not adequately recovered from major surgery or has ongoing surgical complications","ALL","18 Years",{"count":330,"type":331},250,"ESTIMATED","INTERVENTIONAL",[334],"PHASE1","Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.",[337],"Malignant Neoplasm","2026-08-06",{"date":340,"type":341},"2026-08-10","ACTUAL",{"date":343,"type":341},"2025-12-16",{"date":345,"type":331},"2030-12-01",{"name":5,"class":6},21]